饮食和肠道微生物群在预防妊娠期糖尿病中的相互作用:叙述性审查
Luiza-Andreea Beldie1, Cristina-Camelia Dica1, Maria Moța2
1Department of Diabetes, Nutrition and Metabolic Diseases, County Clinical Emergency Hospital of Craiova, 200642 Craiova, Romania.
Nutrients
|December 17, 2024
概括
肠道微生物群的改变,或失生症,与诸如妊娠期糖尿病 (GDM) 等非传染性疾病有关. 健康的饮食可以通过保护肠道微生物群来预防GDM,提供新的治疗方法.
科学领域:
- 微生物学 微生物学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 肠道失调与非传染性疾病有关,包括2型糖尿病和妊娠期糖尿病 (GDM) 等代谢障碍.
- 孕期糖尿病 (GDM) 是一个重要的公共卫生问题,因为它的高频率和相关的孕产妇和胎儿并发症.
- 关于肠道失调-GDM联系的研究正在不断发展,正在进行的研究不断提供新的见解.
研究的目的:
- 审查健康饮食的机制,通过保护肠道微生物群,可以预防GDM.
- 探索基于肠道微生物群调节的GDM管理的医学营养治疗策略.
主要方法:
- 这篇叙事综述综合了当前关于肠道微生物群,失生症和GDM的研究.
- 它考察了饮食在维持肠道健康方面的作用及其在GDM预防和管理方面的潜力.
主要成果:
- 新出现的证据表明,肠道失调和GDM发展之间存在强烈的关联.
- 旨在促进健康肠道微生物群的饮食干预措施可能是预防GDM的有希望的策略.
结论:
- 通过饮食调节肠道微生物群代表了预防GDM的潜在途径.
- 需要进一步的研究来充分阐明这些机制,并将研究结果转化为GDM管理的临床实践.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Pathophysiology of Diabetes
862
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
862
Oral Hypoglycemic Agents: Biguanides and Glitazones
168
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
168
Dipeptidyl Peptidase 4 Inhibitors
167
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
167
Anatomy of the Intestines
71.3K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
71.3K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315


